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ABSTRACT 
Inflammatory bowel diseases (IBD) are characterised by chronic inflammation of the 
gastrointestinal tract including the colon (colitis). Increased dietary intake of salmon, 
which is rich in eicosapentaenoic acid (EPA), was well tolerated by IBD patients, leading 
to a perceived decrease in symptoms. However, better knowledge of the mechanisms by 
which EPA-rich diets affect IBD severity, and appropriate biomarkers for assessing these 
effects, are needed for potential targeted nutritional interventions. 
This dissertation aimed to determine the temporal effects (early (9 weeks of age) 
vs. established (12 weeks)) of a diet containing 3.7% EPA, and the dose-dependent effects 
(15% to 45%) of a salmon diet at 12 weeks of age, on the severity of colitis. Molecular 
responses in colon and/or liver of the interleukin-10 gene-deficient (Il10-/-) mouse model 
of IBD and healthy mice were assessed. Caecum digesta, urine and blood were mined to 
identify biomarkers (microbiota, metabolites and genes) of these responses.  
The EPA diet reduced the severity of colitis only in 12-week-old Il10-/- mice. 
This response was associated with changes in gene expression associated with 
lymphocyte function, eicosanoid signalling and peroxisome proliferator-activated 
receptor gamma signalling. The blood immune cell gene expression profile did not 
correlate with reduced colitis in these mice, but the urine metabolite profile was related 
to changes in colonic tryptophan metabolism.  
The effects of the salmon diets on colitis were dose-dependent in 12-week-old 
Il10-/- mice. The intermediate amount of salmon (30%) reduced the severity of colitis and 
lymphocyte-related gene expression, while enhancing genes in metabolic pathways. 
Tryptophan metabolism was not affected in these mice, but the urinary metabolite profile 
correlated with effects on hepatic tocopherol metabolism, as shown by reduced 
abundance of gamma-carboxyethylhydroxychroman glucoside. The abundances of V. 
akkermansia, Eubacterium spp., and an unclassified Rikenellaceae were further affected 
in these mice.  
This is the first report describing molecular responses in the colon and liver of 
Il10-/- mice fed a salmon diet associated with reduced colitis. Ultimately these responses 
could be validated for use in humans, and potentially enable management of IBD with 
diet. 
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